vs
Side-by-side financial comparison of AerSale Corp (ASLE) and CorMedix Inc. (CRMD). Click either name above to swap in a different company.
CorMedix Inc. is the larger business by last-quarter revenue ($128.6M vs $90.9M, roughly 1.4× AerSale Corp). CorMedix Inc. produced more free cash flow last quarter ($92.7M vs $9.8M).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.
ASLE vs CRMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $128.6M |
| Net Profit | $5.4M | — |
| Gross Margin | 34.1% | 83.4% |
| Operating Margin | 7.8% | 46.0% |
| Net Margin | 5.9% | — |
| Revenue YoY | -4.0% | — |
| Net Profit YoY | 99.7% | — |
| EPS (diluted) | $0.10 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $128.6M | ||
| Q3 25 | $71.2M | $104.3M | ||
| Q2 25 | $107.4M | $39.7M | ||
| Q1 25 | $65.8M | $39.1M | ||
| Q4 24 | $94.7M | — | ||
| Q3 24 | $82.7M | — | ||
| Q2 24 | $77.1M | — | ||
| Q1 24 | $90.5M | — |
| Q4 25 | $5.4M | — | ||
| Q3 25 | $-120.0K | $108.6M | ||
| Q2 25 | $8.6M | $19.8M | ||
| Q1 25 | $-5.3M | $20.6M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $509.0K | — | ||
| Q2 24 | $-3.6M | — | ||
| Q1 24 | $6.3M | — |
| Q4 25 | 34.1% | 83.4% | ||
| Q3 25 | 30.2% | 89.3% | ||
| Q2 25 | 32.9% | 95.3% | ||
| Q1 25 | 27.3% | 95.9% | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 7.8% | 46.0% | ||
| Q3 25 | 4.0% | 49.2% | ||
| Q2 25 | 11.7% | 49.2% | ||
| Q1 25 | -10.1% | 51.5% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | -2.4% | — | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 5.9% | — | ||
| Q3 25 | -0.2% | 104.1% | ||
| Q2 25 | 8.0% | 49.9% | ||
| Q1 25 | -8.0% | 52.8% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | 6.9% | — |
| Q4 25 | $0.10 | $0.20 | ||
| Q3 25 | $0.00 | $1.26 | ||
| Q2 25 | $0.18 | $0.28 | ||
| Q1 25 | $-0.10 | $0.30 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $148.5M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $405.3M |
| Total Assets | $640.5M | $826.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $148.5M | ||
| Q3 25 | $5.3M | $55.7M | ||
| Q2 25 | $5.7M | $190.7M | ||
| Q1 25 | $4.7M | $77.5M | ||
| Q4 24 | $4.7M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $4.3M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $405.3M | ||
| Q3 25 | $417.1M | $374.1M | ||
| Q2 25 | $415.9M | $220.6M | ||
| Q1 25 | $406.5M | $114.9M | ||
| Q4 24 | $455.6M | — | ||
| Q3 24 | $451.5M | — | ||
| Q2 24 | $449.8M | — | ||
| Q1 24 | $452.0M | — |
| Q4 25 | $640.5M | $826.1M | ||
| Q3 25 | $646.3M | $750.9M | ||
| Q2 25 | $646.7M | $252.6M | ||
| Q1 25 | $646.1M | $149.6M | ||
| Q4 24 | $604.7M | — | ||
| Q3 24 | $601.5M | — | ||
| Q2 24 | $598.7M | — | ||
| Q1 24 | $571.7M | — |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $94.5M |
| Free Cash FlowOCF − Capex | $9.8M | $92.7M |
| FCF MarginFCF / Revenue | 10.8% | 72.1% |
| Capex IntensityCapex / Revenue | 1.7% | 1.3% |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $172.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $94.5M | ||
| Q3 25 | $-8.9M | $30.9M | ||
| Q2 25 | $19.8M | $30.0M | ||
| Q1 25 | $-45.2M | $19.7M | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $-15.3M | — | ||
| Q1 24 | $-21.5M | — |
| Q4 25 | $9.8M | $92.7M | ||
| Q3 25 | $-9.8M | $30.4M | ||
| Q2 25 | $18.6M | $30.0M | ||
| Q1 25 | $-47.6M | $19.7M | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-25.0M | — |
| Q4 25 | 10.8% | 72.1% | ||
| Q3 25 | -13.8% | 29.1% | ||
| Q2 25 | 17.3% | 75.4% | ||
| Q1 25 | -72.4% | 50.5% | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -24.6% | — | ||
| Q1 24 | -27.7% | — |
| Q4 25 | 1.7% | 1.3% | ||
| Q3 25 | 1.3% | 0.5% | ||
| Q2 25 | 1.1% | 0.1% | ||
| Q1 25 | 3.7% | 0.0% | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | 2.31× | 1.51× | ||
| Q1 25 | — | 0.96× | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
